Copyright
©The Author(s) 2022.
World J Clin Cases. Apr 6, 2022; 10(10): 3027-3034
Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3027
Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3027
Table 4 Toxicity and side effect rate in the two groups, n (%)
| Group | Headache | Ataxia | Drowsiness | Toxicity and side effect rate |
| Experimental group (n = 49) | 2 (4.08) | 2 (4.08) | 1 (2.04) | 5 (10.20) |
| Control group (n = 47) | 1 (2.13) | 3 (6.38) | 2 (4.26) | 6 (12.76) |
| χ2 | - | - | - | 0.155 |
| P value | - | - | - | 0.694 |
- Citation: Du D, Qiao Q, Guan Z, Gao YF, Wang Q. Combined sevoflurane-dexmedetomidine and nerve blockade on post-surgical serum oxidative stress biomarker levels in thyroid cancer patients. World J Clin Cases 2022; 10(10): 3027-3034
- URL: https://www.wjgnet.com/2307-8960/full/v10/i10/3027.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i10.3027